Authors: Matthay, KK Panina, C Huberty, J Price, D Glidden, DV Tang, HR Hawkins, RA Veatch, J Hasegawa, B

Citation: Kk. Matthay et al., Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma. treated with I-131-MIBG, J NUCL MED, 42(11), 2001, pp. 1713-1721

Authors: Kanaya, AM Glidden, DV Chambers, HF

Citation: Am. Kanaya et al., Identifying pulmonary tuberculosis in patients with negative sputum smear results, CHEST, 120(2), 2001, pp. 349-355

Authors: Para, MF Glidden, DV Coombs, RW Collier, AC Condra, JH Craig, C Bassett, R Leavitt, R Snyder, S McAuliffe, V Boucher, C

Citation: Mf. Para et al., Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS Clinical Trials Group protocol 333, J INFEC DIS, 182(3), 2000, pp. 733-743

Authors: Glidden, DV Wei, LJ

Citation: Dv. Glidden et Lj. Wei, Rank estimation of treatment differences based on repeated measurements subject to dependent censoring, J AM STAT A, 94(447), 1999, pp. 888-895

Authors: Glidden, DV Self, SG

Citation: Dv. Glidden et Sg. Self, Semiparametric likelihood estimation in the Clayton-Oakes failure time model, SC J STAT, 26(3), 1999, pp. 363-372

Authors: Glidden, DV

Citation: Dv. Glidden, Checking the adequacy of the gamma frailty model for multivariate failure times, BIOMETRIKA, 86(2), 1999, pp. 381-393